Jul 07, 2025
1:15
For every 15 shares held, investors received 1. The price per share adjusted from $0.24 to $0.02.
The split itself did not change the total investment value.
Cyclacel Pharmaceuticals, Inc. (CYCC) trades on the NASDAQ Capital Market in the Biotechnology industry.
Cyclacel Pharmaceuticals, Inc. company overviewThe latest split shown was on July 7, 2025. It was a 1-for-15 reverse split, so shareholders received 1 share for every 15 they held.
This history records 7 reverse splits between March 27, 2006 and July 7, 2025.